- Regeneron Pharmaceuticals (NYSE: REGN) Inc. stock price is trading below 20, 50-day Exponential Moving Average, and above 100-day EMA levels.
- Regeneron Pharmaceuticals Companies Inc.’s market cap is $76.96 Billion.
As per the current market scenario, the stock price of Regeneron Pharmaceuticals (NYSE: REGN) is moving in an upward direction.
The Regeneron Pharma price is currently trading near its all-time high. A few weeks ago, price made an all-time high of $837.55. The price has declined by -14% in the last few weeks.
The 1-year return of Regeneron Pharmaceuticals (NYSE: REGN) is 19.98% which is more than the forecasted growth for the stock. This shows REGN stock is performing well.
Regeneron Pharmaceuticals’ (REGN) P/E ratio is 18.42, which suggests that the stock is not expensive and at a fair value.
Regeneron Pharmaceuticals (REGN) Stock Price Analysis

EMA (Exponential Moving Average)
Based on the current market scenario in the weekly timeframe, Regeneron Pharmaceuticals (REGN) shares are trading in a bullish crossover indicating upmove in the future.
MACD (Moving Average Convergence Divergence)
In the weekly time frame, the RSI for the REGN is indicating a downtrend as the stock is in the retracement phase. Hence, if MACD results in a bullish crossover the market can result in a good uptrend.
RSI (Relative Strength Index)
The RSI for Regeneron Pharmaceuticals (REGN) is trading at a level of 44.8 but still looks bullish as it has not yet broken the level of 35 which indicates that the market can rebound in the future .
Volume Analysis
A rise in volume on the Regeneron Pharma (REGN) chart is a sign that buyers are becoming more interested. This increase in activity can lead the price to move higher.
Conclusion
In conclusion, the analysis suggests that Regeneron Pharma (REGN) has a favorable market structure and significant positive momentum. This upbeat picture is further supported by important indicators like RSI, and EMA, which indicate that there is a chance that the price of Regeneron Pharmaceuticals will move upward and rise in the future.
Technical Levels
- Support – The current support level of Regeneron Pharmaceuticals (REGN) stock is $685.00.
- Resistance -The current resistance level of the Regeneron Pharmaceuticals (REGN) stock is $778.
Disclaimer
The views and opinions of the author, or anyone named in this article, are for informational purposes only. They do not offer financial, investment, or other advice. Investing or trading crypto assets involves the risk of financial loss.




